Registry of Arthrex Hand and Wrist Products
Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products
1 other identifier
observational
650
1 country
5
Brief Summary
A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Effectiveness of Hand and Wrist Products
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2021
CompletedFirst Submitted
Initial submission to the registry
August 31, 2021
CompletedFirst Posted
Study publicly available on registry
September 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJune 26, 2025
June 1, 2025
4.4 years
August 31, 2021
June 23, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To assess a change in Visual Analogue Scale (VAS) survey
Patient reported pain scale 0-10 point scale (0 min,10 max)
Preoperatively, 3 months, 6 months and 12 months postoperatively
Secondary Outcomes (1)
To assess a change in Veterans Rand 12-Item Health Survey (VR-12)
Preoperatively, 3 months, 6 months and 12 months postoperatively
Other Outcomes (1)
Quick Disabilities of the Arm, Shoulder and Hand Score (QDASH).
Preoperatively, 3 months, 6 months and 12 months postoperatively
Study Arms (1)
All Products listed in Descriptions
Biocomposite™ or PEEK PushLock, DX SwiveLock SL, Headless Compression Screws, Tenodesis Screw (Biocomposite and PEEK), Corkscrew® Titanium (Nano and Micro-Corkscrew), DynaNite Nitinol Staples KreuLock Screws
Interventions
Depending on approved indication per product
Eligibility Criteria
Approximately 50 subjects, male and female, 18 years of age or older will be enrolled for each product and material. Subjects will be recruited from the surgeon's patient population or referrals from other physicians.
You may qualify if:
- Subject requires surgery using Arthrex hand and wrist implants included in the registry.
- Subject is 18 years of age or over.
- Subject is not considered a vulnerable subject (i.e. child, pregnant, nursing, prisoner, or ward of the state).
- Subject signed informed consent and is willing and able to comply with all registry requirements
You may not qualify if:
- Insufficient quantity or quality of bone.
- Blood supply limitations and previous infections, which may retard healing.
- Foreign-body sensitivity or foreign-body reactions.
- Any active infection or blood supply limitations.
- Conditions that tend to limit the patient's ability or willingness to restrict activities or follow directions during the healing period.
- Subjects that are skeletally immature -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Arthrex, Inc.lead
Study Sites (5)
MORE Foundation
Phoenix, Arizona, 85023, United States
Banner Health
Tuscon, Arizona, 85006, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Duke University
Durham, North Carolina, 27705, United States
West Virginia University
Morgantown, West Virginia, 26501, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 31, 2021
First Posted
September 16, 2021
Study Start
July 20, 2021
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
June 26, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share